and S. motivated in Compact disc4+ cells by movement cytometry. Compact disc4+ cells had been classified in Compact disc4+Compact disc25high [regulatory T cells (Tregs)] and Compact disc4+Compact disc25low (regular activated) according with their Compact disc25 fluorescence strength. Results are portrayed as amount of Compact disc4+Compact disc25high or Compact disc25low expressing LAP+ cells in 1 106 cultured PBMC (Mtb\activated cells (Friedman check accompanied by Dunn’s check); (a)?=?PPD+ HD (KruskalCWallis figures followed by Dunn’s test). (b). PBMC from six MDR\TB patients were stimulated for 48 h alone or with strains, in the presence or not of anti\TLR\2 or anti\TLR\4 monoclonal antibodies. Then the number of CD4+CD25high/low LAP+ cells was determined. Box\plots show median and 25thC75th percentiles with maximum and minimum values. Statistical differences: *non\treated PBMC (Friedman test followed by Dunn’s test). CEI-187-160-s002.tif (1.0M) GUID:?D1014CC5-C661-4EBD-9C7A-BAFA9C156EBF Fig. S3. Schematic model representing the mechanisms used by M strain to induce high levels of transforming growth factor (TGF)\ secretion by antigen\presenting MCB-613 cells (APCs) and CD4+latency\associated protein (LAP)+ T cells leading to the interleukin (IL)\17+interferon (IFN)\C cell subset expansion in multi\drug\resistant tuberculosis (MDR\TB) patients. Upper panel: IL\17 secretion: antigen\presenting cells (APCs) from MDR\TB patients and purified protein derivative (PPD)+ healthy donors (HD) recognize (strains through TLR\4 and together with IL\23 promote IL\17+IFN\+ cell expansion (green panel). In the case of MDR\TB patients, APCs recognize M strain via TLR\2 secreting large amounts of TGF\. Additionally, M strain can be recognized further by CD4+CD25highforkhead box protein 3 (FoxP3+) [regulatory T cells (Treg)] and CD4+CD25lowFoxP3C (conventional activated cells) through TLR\2, inducing up\regulation of the LAP/TGF\ complex (LAP) expression and promoting the expansion of both subsets. TGF\ secreted by APCs and CD4+LAP+ T cells acts jointly with IL\23 to MCB-613 support the marked expansion of IL\17+IFNCCD4+ T cells (pink panel), which are responsible for the enhanced T helper type 17 (Th17) response observed in MDR\TB patients. CEI-187-160-s003.tif (6.8M) GUID:?F9B81D92-C4F7-4D90-BE9C-192B59C89A55 Table S1. Additional clinical feature of tuberculosis (TB) patients. CEI-187-160-s004.pdf (14K) GUID:?2AFA22F7-E510-423E-85DE-ED0C397958D7 Summary We have reported previously that T cells from patients with multi\drug\resistant tuberculosis (MDR\TB) express high levels of interleukin (IL)\17 in response to the MDR strain M (Haarlem family) of (strain on the Th17 response. strains. This increase was associated with a differential expansion of MCB-613 IL\17+IFN\C within the CD4+ T cell subset, and this effect was more evident when the M strain was used as an antigen 19. In the present work we explore the underlying mechanisms involved in IL\17+IFN\C and IL\17+IFN\+ memory T cell expansion, taking into account the genotype of the infecting strains. Methods Ethics statement This work was carried out in accordance with the revised version of the Declaration of Helsinki (2013) of the World Medical Association, and was reviewed and approved by the following bioethics committees: Academia Nacional de Medicina (Decision Number 23\03\2010), Hospital Mu?iz (DN 131\07, Project Number 145) and the Teaching and Research Committee MUC12 of the Buenos Aires City government (DN 1217 2010). Patients Blood samples were obtained from MDR\TB patients hospitalized at the Phthisiopneumonology Institute University of Buenos Aires in the F. J. Mu?iz Hospital, Buenos Aires, Argentina. Patient informed consent was obtained according to the guidelines of the ethics committee of the F. J. Mu?iz Hospital. All patients were diagnosed by the presence of recent clinical respiratory symptoms, abnormal chest radiography, a sputum smear test positive for acid\fast bacilli (AFB) and the identification of in culture. Exclusion criteria included a positive test for HIV and the presence of concurrent infectious diseases or non\infectious conditions (cancer, diabetes or steroid therapy). Sputum smear examination and mycobacterial culture were performed in agreement with standard procedures. Susceptibility to isoniazid, rifampicin, ethambutol and streptomycin was determined according to World Health Organization standards. Susceptibility to kanamycin, isolates were.